Jul 25, 2023 / 06:00PM GMT
Unidentified Participant
Hello, and welcome again to the Second Annual H.C. Wainwright Kidney Conference. I'm very pleased to have with us our next presenting company, Ardelyx and representing the company is President and CEO, Mike Raab.
Mike, thank you so much for joining us.
Mike Raab - Ardelyx, Inc. - President & CEO
Of course, and good afternoon, everyone. Thank you, H.C. Wainwright for inviting us to this year's Kidney Conference, and really glad to be here and thank you for putting us on. I think it's a critical focus area that we need to as a society and our business be focused more on what's happening with kidney disease.
And ultimately, patients on dialysis, obviously be making forward-looking statements. So if you need any more information on that, you can see in our 10-Q or at the Ardelyx website.
Now, while most of the time I'll be spending today is going to be focused on XPHOZAH and depending we hope approval on October 17, I do want to spend a little bit of time on IBSRELA. It was approved in and we launched last year in
Ardelyx Inc at HC Wainwright Kidney Virtual Conference Transcript
Jul 25, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers